Farmacologia y Toxicologia
- ISSN: 2174-8365
-
Journal h-index: 1
- Average acceptance to publication time (5-7 days)
-
Average article processing time (30-45 days)
Less than 5 volumes 30 days
8 - 9 volumes 40 days
10 and more volumes 45 days
Parkinson's disease (PD) is a complex neurodegenerative age-related disease associated with loss of dopaminergic cells and both motor and non-motor disorders. PD is the second most common neurodegenerative disease that affects above 85 years of age and affects 2% of the population over 60 years of age. PD is the brain's reward that causes typical motor symptoms such as tremor, bradykinesia, rigidity, contraction, as well as non-motor symptoms such as executive dysfunction, mood and sleep disturbance, with constant loss of dopaminergic neurons in the substantia nigra (black substance) of the midbrain. It is defined as a disease caused by dopamine deficiency, a neurotransmitter that helps control learning and emotional centers [1-4].
